2022 / 06

Next Paper
DOI: 10.24075/brsmu.2022.059

ORIGINAL RESEARCH

The role of mef and ermB drug resistance genetic markers in the selection of fecal microbiota donors

Gospodaryk AV1, Ulakhanova LA1, Esiev SS1, Polyakova EV1, Shansky YD1, Bespyatykh JA1,2,3
About authors

1 Lopukhin Federal Research and Clinical Center Of Physical-Chemical Medicine under the Federal Medical Biological Agency, Moscow, Russia

2 Mendeleev University of Chemical Technology of Russia, Moscow, Russia

3 Semashko National Research Institute of Public Health, Moscow, Russia

Correspondence should be addressed: Alina V. Gospodaryk
Krasnogorskoe shosse, 15, Odintsovo, Moscow region, 143007, Russia; gro.mcpcr@kiradopsog.anila

About paper

Funding: Grant of ANO Moscow Center for Innovative Technologies in Healthcare (#2412-31).

Author contribution: Gospodaryk AV — selection of study participants, PCR analysis of biological samples, literature analysis, article authoring; Ulakhanova LA — literature analysis, article authoring, fecal culture, bacteriological analysis; Esiev SS — literature analysis, isolation of nucleic acids from biological samples; Polyakova EV — practical part of the bacteriological analysis, isolation of nucleic acids from biological samples; Shansky YD — statistical data processing; Bespyatykh JA — study concept, consulting, article authoring and editing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Federal Research and Clinical Center Of Physical-Chemical Medicine under the Federal Medical Biological Agency of Russia (Minutes #2022/05/31 of May 31, 2022). All study participants signed the voluntary informed consent form.

Received: 2022-10-20 Accepted: 2022-11-25 Published online: 2022-12-16
|
  1. Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017; 66 (4): 569–80. DOI: 10.1136/gutjnl-2016-313017.
  2. Baunwall SMD, Lee MM, Eriksen MK, Mullish BH, Marchesi JR, Dahlerup JF, et al. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis. EClinicalMedicine. 2020; 23: 29–30. PMID: 33437951; PMCID: PMC7788438. DOI: 10.1016/j.eclinm.2020.100642.
  3. Wang Y, Zhang S, Borody T, Zhang F. Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases. Chinese Medical Journal. 2022; 10.1097/CM9.0000000000002339 DOI: 10.1097/ CM9.0000000000002339.
  4. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108 (4): 478–98.
  5. Debast SB, Bauer MP, Kuijper EJ, European Society of Clinical M, Infectious D: European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014; 20 (Suppl 2): 1–26.
  6. Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies. 2013; www.fdagov.
  7. Shherbakov PL, Belova ND, Generozov EhV, Zhgun ES, Ivanova OI, Il'ina EN, i dr. Primenenie fekal'noj transplantacii v lechenii zabolevanij pishhevaritel'nogo trakta (pervyj klinicheskij opyt). Doktor.Ru. 2019; 3 (158): 40–46. DOI: 10.31550/1727-23782019-158-3-40-46. Russian.
  8. Yakupova AA, Abdulxakov SR, Safin AG, Alieva IM, Oslopova YuV, Abdulxakov RA. Transplantaciya fekal'noj mikrobioty: kriterii vybora donora, podgotovki i xraneniya biomateriala (obzor sovremennyx rekomendacij). Terapevticheskij arxiv. 2021; 93 (2): 215–21. DOI: 10.26442/00403660.2021.02.200615. Russian.
  9. Ehjdelshtejn MV. Ehkstremal'no- i panrezistentnye klony bakterial'nyx vozbuditelej v klinike. Tezisy dokladov ezhegodnoj Vserossijskoj nauchno-prakticheskoj konferencii s mezhdunarodnym uchastiem «Kontrol' i profilaktika infekcij, svyazannyx s okazaniem medicinskoj pomoshhi (ISMP-2015)», 25 noyabrya 2015, Moskva Zhurnal MediAl'. 2015, 3 (17). Russian.
  10. Turkutyukov VB. Molekulyarno-geneticheskij monitoring rezistentnosti mikroorganizmov k antibiotikam. Tixookeanskij medicinskij zhurnal. 2011; 2 (44): 28–31. Russian.
  11. Zhuangab M, Achmonab Y, Cao Y, Liang X, Chen L, Wange H, et. al. Distribution of antibiotic resistance genes in the environment. Environmental Pollution. 2021; 285. Article 117402. DOI. org/10.1016/j.envpol.2021.117402.
  12. Roberts MC. Environmental macrolide–lincosamide–streptogramin and tetracycline resistant bacteria Front. Microbiol. 2011. Available from: https://doi.org/10.3389/fmicb.2011.00040.
  13. Katosova LK, Lazareva AV, Xoxlova TA., Ponomarenko OA, Alyabeva NM. Rasprostranenie i mexanizmy ustojchivosti k makrolidam Streptococcus pyogenes, vydelennyx u detej. Antibiotiki i ximioterapiya. 2016; 61 (3–4): 23–29. Russian.
  14. Farrell DJ, Morrissey I, Bakker S, Morris L, Buckridge S, Felmingham D. Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)mediated macrolide resistance. J Clin Microbiol. 2004; 42 (2): 764–8. DOI: 10.1128/JCM.42.2.764–768.2004. PMID: 14766850; PMCID: PMC344484.
  15. Reinert RR, Ringelstein A, van der Linden M, Cil MY, Al-Lahham A, Schmitz FJ. Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe. J Clin Microbiol. 2005; 43 (3): 1294–300. DOI: 10.1128/JCM.43.3.12941300.2005. PMID: 15750098; PMCID: PMC1081259.
  16. Ikryannikova LN, Senina ME, Lisicina ES, Ogorodova LM, Fedosenko SV, Karnaushkina MA, i dr. Vidovaya identifikaciya i analiz geneticheskix markerov lekarstvennoi ustoichivosti streptokokkov ̆ s pomoshh'yu kolichestvennoi mul'tipleksnoĭ polimeraznoĭ cepnoĭ ̆ reakcii u pacientov s xronicheskoi obstruktivnoĭ bolezn'yu legkix. ̆ Pul'monologiya. 2014; (6): 40–48. Dostupno po ssylke: https://doi. org/10.18093/0869-0189-2014-0-6-40-48. Russian.
  17. Fedosenko SV, Ogorodova LM, Ilina EN, Senina ME, Lisicina ES, Karnaushkina MA, i dr. Geneticheskie determinanty ustojchivosti orofaringeal'nyx streptokokkov k antibakterial'nym sredstvam u pacientov s xronicheskoj obstruktivnoj bolezn'yu legkix i bol'nyx bronxial'noj astmoj. Terapevticheskij arxiv. 2015; 87 (8): 51–57. DOI: 10.17116/terarkh201587851-57. Russian.
  18. Gosalbes MJ, Vallès Y, Jiménez-Hernández N, Balle C, Riva P, Miravet-Verde S, et al. High frequencies of antibiotic resistance genes in infants’ meconium and early fecal samples. J Dev Orig Health Dis. 2016; 7: 35–44. DOI: 10.1017/S2040174415001506.
  19. Ehpshtejn-Litvak RV, Vilshanskaya FL. Bakteriologicheskaya diagnostika disbakterioza kishechnika. Metodicheskie rekomendacii. M., 1977; 20 s. Russian.
  20. Protokol vedeniya bol'nyx. Disbakterioz kishechnika: OST 91500.11.0004-2003. Prikaz Minzdrava Rossii # 231 ot 09.06.03. (Otraslevoj standart). Russian.
  21. U.S. Food and Drug Administration. Information pertaining to additional safety protections regarding use of fecal microbiota for transplantation — screening and testing of stool donors for multidrug resistant organisms. 2019. Available from: https://www. fda.gov/vaccines-blood-biologics/safety-availability-biologics/ information-pertaining-additional-safety-protections-regardinguse-fecal-microbiota-transplantation.
  22. Klassert TE, Zubiria-Barrera C, Kankel S, Stock M, Neubert R, Lorenzo-Diaz F, et.al. Early Bacterial Colonization and Antibiotic Resistance Gene Acquisition in Newborns. Front Cell Infect Microbiol. 2020; 10: 332. DOI: 10.3389/fcimb.2020.00332. PMID: 32754449; PMCID: PMC7366792.
  23. Zhang K, Jin M, Yang D, Shen Z, Liu W, Yin J, et al. Antibiotic resistance genes in gut of breast-fed neonates born by caesarean section originate from breast milk and hospital ward air. BMC Microbiol 22. 2022; 36. DOI: org/10.1186/s12866-022-02447-8.
  24. Huang MS, Cheng CC, Tseng SY, Lin YL, Lo HM, Chen PW. Most commensally bacterial strains in human milk of healthy mothers display multiple antibiotic resistance. Microbiology Open. 2019; 8 (1): e00618 doi.org/10.1002/mbo3.618.
  25. Carvalho MJ, Sands K, Thomson, Portal KE, Mathias J, Milton R, et al. Antibiotic resistance genes in the gut microbiota of mothers and linked neonates with or without sepsis from low- and middleincome countries. Nat Microbiol. 2022; 7: 1337–47. Available from: doi.org/10.1038/s41564-022-01184-y.